We are live on !
Find out more
HighMark Wealth Management Portfolio holdings
AUM
$299M
Turnover
13.67%
1-Year Est. Return
53.01%
This Fund
S&P 500
This Quarter Est. Return
+21.77%
1 Year Est. Return
+53.01%
3 Year Est. Return
+109.68%
5 Year Est. Return
+113.63%
10 Year Est. Return
–
AUM
$299M
AUM Growth
+$52.9M
(+22%)
Cap. Flow
+$8.26M
Cap. Flow % of AUM
Cap. Flow %
2.77%
Top 10 Holdings %
Top 10 Hldgs %
65.82%
Holding
600
New
46
Increased
156
Reduced
94
Closed
36
Avg Time Held
Equity + Options
3.4
years
Top 10 Avg Time Held
Equity + Options
2.7
years
Top 20 Avg Time Held
Equity + Options
2.3
years
Avg Time Held Equity only
3.4
years
Top 10 Avg Time Held Equity only
2.7
years
Top 20 Avg Time Held Equity only
2.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fidelity MSCI Health Care Index ETF
FHLC
|
+$18.3M |
| 2 |
SI-BONE Inc
SIBN
|
+$3.79M |
| 3 |
Duos Technologies
DUOT
|
+$2.91M |
| 4 |
Apogee Therapeutics
APGE
|
+$2.91M |
| 5 |
Neuropace
NPCE
|
+$1.61M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CNTA
Centessa Pharmaceuticals
CNTA
|
+$9.41M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$5.14M |
| 3 |
AnaptysBio
ANAB
|
+$3.29M |
| 4 |
iShares MSCI EAFE Value ETF
EFV
|
+$1.64M |
| 5 |
Piper Sandler
PIPR
|
+$1.27M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 64.9% |
| 2 | Healthcare | 21.84% |
| 3 | Technology | 4.77% |
| 4 | Financials | 3.58% |
| 5 | Industrials | 1.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
326
US Foods
USFD
$23.2B
| $9.41K | ﹤0.01% |
92
| – | – |
2024 Q4
6 quarters
|
|
327
Fidelity Enhanced Small Cap Core ETF
FESM
$6.5B
| $9.24K | ﹤0.01% |
191
| – | – |
2024 Q2
8 quarters
|
|
328
DELISTED
SkyWater Technology
SKYT
| $9.23K | ﹤0.01% |
265
| – | – |
2026 Q1
1 quarter
|
|
329
Steel Dynamics
STLD
$31.8B
| $9.18K | ﹤0.01% |
40
+2
| +5% | +$468 |
2025 Q2
4 quarters
|
|
330
J.M. Smucker
SJM
$14.2B
| $9.11K | ﹤0.01% |
81
| – | – |
2025 Q3
3 quarters
|
|
331
Goldman Sachs
GS
$252B
| $9.1K | ﹤0.01% |
9
| – | – |
2024 Q3
7 quarters
|
|
332
American Airlines Group
AAL
$8.44B
| $9.04K | ﹤0.01% |
500
| – | – |
2022 Q1
17 quarters
|
|
333
Microchip Technology
MCHP
$36.3B
| $8.94K | ﹤0.01% |
98
+5
| +5% | +$446 |
2025 Q4
2 quarters
|
|
334
Welltower
WELL
$180B
| $8.85K | ﹤0.01% |
39
-2
| -5% | -$423 |
2025 Q2
4 quarters
|
|
335
Boston Scientific
BSX
$63.8B
| $8.83K | ﹤0.01% |
207
+19
| +10% | +$1.03K |
2019 Q4
26 quarters
|
|
336
Prothena Corp
PRTA
$410M
| $8.81K | ﹤0.01% |
900
| – | – |
2020 Q4
22 quarters
|
|
337
Antero Resources
AR
$11.3B
| $8.78K | ﹤0.01% |
250
| – | – |
2022 Q4
14 quarters
|
|
338
Centerspace
CSR
$984M
| $8.6K | ﹤0.01% |
153
| – | – |
2022 Q1
17 quarters
|
|
339
Oscar Health
OSCR
$10.6B
| $8.56K | ﹤0.01% |
300
+100
| +50% | +$2.15K |
2025 Q4
2 quarters
|
|
340
Cronos Group
CRON
$1.39B
| $8.34K | ﹤0.01% |
3,000
| – | – |
2025 Q2
4 quarters
|
|
341
Globalstar
GSAT
$10.9B
| $8.13K | ﹤0.01% |
100
| – | – |
2021 Q3
19 quarters
|
|
342
Amplitude
AMPL
$2.05B
| $8.11K | ﹤0.01% |
1,060
+900
| +563% | +$6.21K |
2025 Q4
2 quarters
|
|
343
Viatris
VTRS
$21.8B
| $8.08K | ﹤0.01% |
509
+2
| +0.4% | +$31 |
2020 Q4
22 quarters
|
|
344
Option Care Health
OPCH
$4.73B
| $8.03K | ﹤0.01% |
383
| – | – |
2019 Q4
26 quarters
|
|
345
First Industrial Realty Trust
FR
$7.18B
| $7.97K | ﹤0.01% |
130
| – | – |
2022 Q4
14 quarters
|
|
346
Entergy
ETR
$52.4B
| $7.81K | ﹤0.01% |
68
| – | – |
2025 Q4
2 quarters
|
|
347
MongoDB
MDB
$24.6B
| $7.72K | ﹤0.01% |
23
+7
| +44% | +$2.1K |
2026 Q1
1 quarter
|
|
348
Evolent Health
EVH
$534M
| $7.72K | ﹤0.01% |
1,425
-2,550
| -64% | -$9.8K |
2024 Q3
7 quarters
|
|
349
Agilent Technologies
A
$48.4B
| $7.7K | ﹤0.01% |
58
| – | – |
2025 Q3
3 quarters
|
|
350
Hershey
HSY
$35.3B
| $7.54K | ﹤0.01% |
43
| – | – |
2022 Q1
17 quarters
|
|
Similar funds
BOC
HighMark Wealth Management's Q2 2026 Portfolio in Review
As of Q2 2026, HighMark Wealth Management held 600 positions worth $299M, up 22% from $246M the previous quarter. Its ten largest holdings account for 66% of the portfolio.
HighMark Wealth Management's Q2 2026 filing shows 46 new, 156 increased, 94 reduced and 36 closed positions. Its largest new stake was Duos Technologies: 289,884 shares worth $3.48M. The largest sale was Centessa Pharmaceuticals, an estimated $9.41M.
By sector, the portfolio is most concentrated in Miscellaneous at 65% of assets, down from 65% a quarter earlier, followed by Healthcare and Technology.
- HighMark Wealth Management's largest Q2 2026 buy was Duos Technologies: 289,884 shares worth $3.48M.
- HighMark Wealth Management added most to Fidelity MSCI Health Care Index ETF in Q2 2026, an estimated $18.3M increase.
- HighMark Wealth Management's biggest Q2 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $5.14M.
- HighMark Wealth Management fully exited Centessa Pharmaceuticals in Q2 2026, selling an estimated $9.41M.
- HighMark Wealth Management's ten largest holdings make up 66% of its $299M portfolio in Q2 2026.
- HighMark Wealth Management opened 46 new positions and closed 36 in Q2 2026.
- HighMark Wealth Management's portfolio value rose 22% quarter-over-quarter to $299M.
Based on HighMark Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.